Atlas Trials

Multiple Dose Escalating Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ASP1941

Clinical trial NCT01288898 · COMPLETED

Trial details

NCT number
NCT01288898
Sponsor
Astellas Pharma Inc
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Healthy
Start date
2007-05-01
Primary completion
2008-03-01
Enrollment
48

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.